TGF-beta Antibodies: A Novel Treatment for Pulmonary Fibrosis?

Thorax - United Kingdom
doi 10.1136/thx.48.10.953
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

BARD1 Mediates TGF-β Signaling in Pulmonary Fibrosis

Respiratory Research
PulmonaryRespiratory Medicine
2015English

A Critical Assessment of Treatment Options for Idiopathic Pulmonary Fibrosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

TGF-beta Receptors in Pulmonary Arterial Hypertension: The HHT Connection

Advances in Pulmonary Hypertension
2005English

FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2015English

Triptolide Protects Against TGF‑β1‑induced Pulmonary Fibrosis by Regulating FAK/calpain Signaling

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Idiopathic Pulmonary Fibrosis: What Is the Best Treatment?

Barcelona Respiratory Network
2017English

A Novel Neutrophil Derived Inflammatory Biomarker of Pulmonary Exacerbation in Cystic Fibrosis

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2012English

Author's Response: Co-Trimoxazole Treatment in Idiopathic Pulmonary Fibrosis

Thorax
PulmonaryRespiratory Medicine
2013English

Etiology and Treatment of Cough in Idiopathic Pulmonary Fibrosis

Respiratory Medicine
PulmonaryRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy